SecBot SecBot
Home › SEC Filings › Press Releases

Press Releases

10,000+ reports analyzed by SecBot AI · browse by date or by stock
TickerTypeSentimentImpactSummaryDate
LAESPRESS-RELEASEneutral4/10SEALSQ signed a binding letter of intent to acquire satellite capacity and ground infrastructure from WISeSat.Space for Oct 26, 2026
FELEPRESS-RELEASEneutral2/10Franklin Electric declared a quarterly cash dividend of $0.28 per share, payable November 19, 2026, to shareholders of rOct 26, 2026
SAIQPRESS-RELEASEneutral4/10WISeSat.Space announced a binding letter of intent with sister company SEALSQ Corp for a ~$15 million acquisition of capOct 26, 2026
SYKPRESS-RELEASEneutral4/10Stryker has completed the acquisition of ZuriMED, a privately held developer of the FiberLocker System. The deal value aOct 26, 2026
BTCSPRESS-RELEASEneutral3/10BTCS announced a cash tender offer to repurchase up to $500,000 of its Series V Preferred Stock via a modified Dutch aucOct 26, 2026
SENSPRESS-RELEASEneutral4/10Senseonics announced the initiation of a first-in-human clinical study for its investigational 'Freedom' CGM system, whiOct 26, 2026
VHUBPRESS-RELEASEneutral4/10VenHub Global announced a strategic partnership with Follett Higher Education to deploy its autonomous Smart Stores acroOct 26, 2026
RACEPRESS-RELEASEneutral2/10Ferrari disclosed weekly buyback activity under its third tranche of a multi-year €3.5B buyback program. From Oct 19-23,Oct 26, 2026
QUCYPRESS-RELEASEneutral2/10Quantum Cyber presented its antenna technology at QuantumCT's Phase 3 Pilot Collaboration RFP Convening on Quantum SensiOct 26, 2026
OPTTPRESS-RELEASEneutral3/10Ocean Power Technologies announced a non-binding LOI with Stratum Holdings for a strategic collaboration to demonstrate Oct 26, 2026
DAVIPRESS-RELEASEneutral4/10Davion Healthcare Plc acquired the IP of two medical technologies (WoundSkan smart wound dressing and Spektra lateral flOct 26, 2026
XLOPRESS-RELEASEneutral4/10Xilio Therapeutics announced dosing of the first patient in a Phase 1/2 trial of XTX501, a PD-1/masked IL-2 bispecific, Oct 26, 2026
IMRXPRESS-RELEASEneutral3/10Immuneering presented a trial-in-progress poster at ESMO 2026 for its pivotal Phase 3 trial (MAPKeeper 301) evaluating aOct 26, 2026
DAICPRESS-RELEASEneutral2/10CID Holdco (Dot Ai, DAIC) appointed Avi Cohen to its board of directors. Cohen has experience leading technology companiOct 26, 2026
MGNXPRESS-RELEASEbullish6/10MacroGenics announced positive interim Phase 2 LINNET data for lorigerlimab in clear cell gynecologic cancer (CCGC), shoOct 26, 2026
HBTPRESS-RELEASEneutral5/10HBT Financial reported Q3 2026 adjusted EPS of $0.86, beating the $0.79 consensus by 8.9%, with net interest income of $Oct 26, 2026
ABOSPRESS-RELEASEneutral5/10Acumen Pharmaceuticals reported a Q3 2026 net loss of $25.4M ($0.35 per share), slightly narrower than the year-ago $26.Oct 26, 2026
VZPRESS-RELEASEneutral5/10Verizon reported Q3 2026 GAAP EPS of $1.25 (up 6.8% YoY) and Adjusted EPS of $1.31 (up 8.3% YoY), slightly below the $1.Oct 26, 2026
REGNPRESS-RELEASEneutral3/10Regeneron expanded its existing BARDA procurement agreement for Inmazeb, its FDA-approved Ebola treatment, adding approxOct 26, 2026
AZOPRESS-RELEASEneutral3/10AutoZone announced CFO Jamere Jackson's resignation effective November 25, 2026, to join FedEx. An external search for aOct 26, 2026
LKFNPRESS-RELEASEneutral5/10Lake City Bank (LKFN) reported Q3 2026 net income of $28.9M (record), up 9% YoY, with diluted EPS of $1.14 beating the $Oct 26, 2026
VAIPRESS-RELEASEbearish5/10Valor Energy announced a $5M private placement of 2.1M shares at $2.33/share to fund its proposed $3.6M acquisition of aOct 26, 2026
EIKNPRESS-RELEASEbullish6/10Eikon Therapeutics presented updated Phase 2 data for its TLR7/8 agonist EIK1001 in first-line stage 4 NSCLC at ESMO 202Oct 26, 2026
EQTPRESS-RELEASEmixed7/10EQT Corporation will acquire Range Resources in an all-stock transaction valued at 0.987 EQT shares per Range share, creOct 26, 2026
BNTXPRESS-RELEASEbearish6/10BioNTech and DualityBiologics announced that the Phase 3 DYNASTY-Breast02 trial of trastuzumab pamirtecan (BNT323/DB-130Oct 26, 2026
NXPIPRESS-RELEASEbullish6/10NXP Semiconductors has been selected as a strategic technology partner by Volkswagen Group, with its S32K5 microcontrollOct 26, 2026
HCMPRESS-RELEASEbullish7/10HUTCHMED announced positive Phase III SANOVO trial results for ORPATHYS (savolitinib) plus TAGRISSO (osimertinib) in firOct 26, 2026
ESLTPRESS-RELEASEneutral4/10Elbit Systems announced approximately $200 million in contracts from an Asia-Pacific country for airborne ISTAR, traininOct 26, 2026
CTSHPRESS-RELEASEneutral3/10Cognizant announced a five-year strategic partnership with the European Bank for Reconstruction and Development (EBRD) tOct 26, 2026
OPNWPRESS-RELEASEneutral3/10OpenWorld confirmed its planned dual listing on Figure OPEN remains on track for Q4 2026, with stockholder approval of tOct 25, 2026
« Previous Page 12 of 334 Next »